Uracil mustard, a new alkylating agent for oral administration in the management of patients with leukemia and lymphoma.
D000284:Administration, Oral; D000477:Alkylating Agents; D000970:Antineoplastic Agents / Q000628:therapy*; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D008223:Lymphoma / Q000628:therapy*; D014498:Uracil / Q000031:analogs & derivatives; D014499:Uracil Mustard
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D014498:Uracil; D014499:Uracil Mustard
ANTINEOPLASTIC AGENTS/therapy; LEUKEMIA/therapy; LYMPHOMA/therapy; URACIL/related compounds